Skip to main content
. 2021 Oct 20;20:136. doi: 10.1186/s12943-021-01416-5

Fig. 4.

Fig. 4

Strategy used for RCC biomarkers discovery and validation. The Fig. depicts the general strategy used to determine clinically relevant signatures from each generated cell line (i.e. KPT, K-LM and T-LM). For detailed description see Materials and Methods section